Bestimmung des Vorhandenseins von Kontrastmittelflussartefakten
Anmelder: Koninklijke Philips N.V. 🇳🇱
Details
- Veröffentlichungs-Nr.
- EP4792744
- Anmeldetag
- 17. Februar 2025
- Veröffentlichung
- 19. August 2026
- Rechtsraum
- EP
- IPC
- A61B6/00
Abstract
A system (100) for determining a presence of contrast agent flow artifacts, is provided. The system includes one or more processors (110) configured to receive (S110) X-ray attenuation data (120), the X-ray attenuation data representing, at each of a plurality of different points in time (i), a spatial distribution (130<i>) of contrast agent within a vascular region. The one or more processors (110) are also configured to analyze (S120) the X-ray attenuation data (120) to identify one or more differences (140<j>) between the spatial distributions (130<i>). The one or more processors (110) are also configured to determine (S130) a presence of at least one contrast agent flow artifact (150) in the vascular region based on the one or more differences (140<j>).
Anmelder
- Firma
- Koninklijke Philips N.V.
- Land
- 🇳🇱 Niederlande
Niederländisches Technologieunternehmen mit Sitz in Amsterdam, spezialisiert auf Medizintechnik, Diagnosegeräte, Patientenüberwachung sowie Gesundheits- und Wellnessprodukte.
45.118 Patente in unserer Datenbank